Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

(((((( ELITE’S MONSTER LAUNCH IMMINENT !))))))


How soon after approval do you expect to launch the ER CNS product?

Quote:
“Lightning speed. We're going to get approval around the Christmas. I don't know New Year maybe around the corner celebrating with that. No, this will be the most important product we have. As soon as we get approval, Lannett is ready, we are ready, we'll move forward with it. So the question is this is going to take weeks or months, I would go on the week side and hopefully it's in the single digit.”

Adderall XR
ER CNS stimulant
Approved Dec 2019
Launch Imminent
$1.3 Billion market
Milestone and revenues to follow
Only 3 “authorized “ generics which pay royalties to the branded
Competition are “authorized” generics so Elite will have better cost structure
Launch gets Elite Cash Flow Positive Feb-Mar 2020
Stops further dilution
Finances all R&D
Removes going concerns
Pays for trials for unique ADF that is cheaper than those with Naltrexone
Pays for FDA filling of SunGen#5 with $1.5 Billion Market
Massive organic growth

Generic Adderall XR is jointly owned and the second product approval for our Elite and SunGen Pharma LLC ("SunGen") collaboration. Elite will manufacture and package the product on a cost-plus basis. Lannett Company, Inc. will be the exclusive U.S. distributor.

"We are pleased to have received approval of this second product co-developed with our partner, SunGen," said Nasrat Hakim, President and CEO of Elite. "Launch of this product is our top priority."


Quote Nasrat:
“The last SunGen that was filed in May was an extended-release CNS stimulant that we co-developed with our partner SunGen. The branded and generic sales of this product are approximately $1.6 BILLION and there are currently just FOUR meanufacturers which includes the branded and its authorized generics.“
“ This is an outstanding product for us once we get an approval because we will be the fifth in this arena, and even if there were more people than that and we've got just 10% of that market, that's $160 million, a $160 million in revenues will do wonders to Elite stock. Even if we cut it in half between us and SunGen and you take out the actual cost which is another half and walk away with only $40 million, that will take our market cap from 80 million which is today to $800 million with one product only."

“Game Changer” ELTP

——————————————-

Then comes The Monster of them All- GodZilla

SunGen ANDA #5 -THE GRAND DADDY OF THEM ALL Bigger than SunGen #2 another ER CNS stimulant 1.5 Billion + Market

This is the Largest SunGen product Yet !!!***** to date FDA Filing Imminent. All resources on this one. Approval 2020.

Quote Nasrat : “We have another product (SunGen ANDA #5) that we're partnering with SunGen, that’s bigger than SunGen ANDA #2.”